Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGHV2-70 IGHV2-26 IGHV2-5 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	2.94e-13	190	59	12	GO:0003823
GeneOntologyMolecularFunction	P-type sodium transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.42e-08	10	59	4	GO:0008554
GeneOntologyMolecularFunction	P-type sodium:potassium-exchanging transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.42e-08	10	59	4	GO:0005391
GeneOntologyMolecularFunction	P-type potassium transmembrane transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.23e-08	11	59	4	GO:0008556
GeneOntologyMolecularFunction	steroid hormone binding	ATP1A1 ATP1A2 ATP1A3	8.50e-07	7	59	3	GO:1990239
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.77e-06	36	59	4	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.77e-06	36	59	4	GO:0015662
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC8A1 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.12e-05	171	59	6	GO:0015081
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.37e-05	62	59	4	GO:0019829
GeneOntologyMolecularFunction	steroid binding	CD81 ATP1A1 ATP1A2 ATP1A3 STARD5	4.56e-05	133	59	5	GO:0005496
GeneOntologyMolecularFunction	potassium ion transmembrane transporter activity	KCNH8 ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.34e-04	167	59	5	GO:0015079
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	SLC8A1 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.57e-04	301	59	6	GO:0022853
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.03e-04	109	59	4	GO:0042626
GeneOntologyMolecularFunction	transporter activity	SLC25A41 SLC8A1 KCNH8 SLCO4C1 SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4 CLDN2 STARD5	3.28e-04	1289	59	12	GO:0005215
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC8A1 KCNH8 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	4.26e-04	465	59	7	GO:0046873
GeneOntologyMolecularFunction	active transmembrane transporter activity	SLC8A1 SLCO4C1 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	4.96e-04	477	59	7	GO:0022804
GeneOntologyMolecularFunction	transmembrane transporter activity	SLC25A41 SLC8A1 KCNH8 SLCO4C1 SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4 CLDN2	5.96e-04	1180	59	11	GO:0022857
GeneOntologyMolecularFunction	potassium ion binding	ATP1A1 ATP1A2	7.63e-04	14	59	2	GO:0030955
GeneOntologyMolecularFunction	sodium ion binding	ATP1A1 ATP1A2	7.63e-04	14	59	2	GO:0031402
GeneOntologyMolecularFunction	protein-folding chaperone binding	NUP62 ATP1A1 ATP1A2 ATP1A3	1.31e-03	161	59	4	GO:0051087
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	SLC8A1 KCNH8 SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.66e-03	758	59	8	GO:0015318
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF1B ATP1A1 ATP1A2 ATP1A3 ATP1A4 RAD17	1.88e-03	441	59	6	GO:0016887
GeneOntologyMolecularFunction	primary active transmembrane transporter activity	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.90e-03	178	59	4	GO:0015399
GeneOntologyMolecularFunction	ankyrin binding	SLC8A1 ATP1A1	2.09e-03	23	59	2	GO:0030506
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	SLC8A1 KCNH8 SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.21e-03	793	59	8	GO:0015075
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	SLC8A1 KCNH8 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.41e-03	627	59	7	GO:0022890
GeneOntologyMolecularFunction	alkali metal ion binding	ATP1A1 ATP1A2	2.67e-03	26	59	2	GO:0031420
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	SLC8A1 KCNH8 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.32e-03	664	59	7	GO:0008324
GeneOntologyMolecularFunction	hormone binding	ATP1A1 ATP1A2 ATP1A3	3.51e-03	103	59	3	GO:0042562
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IGHV2-70 IGHV2-26 IGHV2-5 CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	1.01e-10	235	62	11	GO:0016064
GeneOntologyBiologicalProcess	B cell mediated immunity	IGHV2-70 IGHV2-26 IGHV2-5 CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	1.51e-10	244	62	11	GO:0019724
GeneOntologyBiologicalProcess	sodium ion export across plasma membrane	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.25e-09	17	62	5	GO:0036376
GeneOntologyBiologicalProcess	adaptive immune response	IGHV2-70 IGHV2-26 IGHV2-5 CD81 IGLV9-49 IGLV8-61 IGLV7-46 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	2.27e-09	838	62	16	GO:0002250
GeneOntologyBiologicalProcess	establishment or maintenance of transmembrane electrochemical gradient	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.40e-08	11	62	4	GO:0010248
GeneOntologyBiologicalProcess	intracellular sodium ion homeostasis	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.80e-08	30	62	5	GO:0006883
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	IGHV2-70 IGHV2-26 IGHV2-5 CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	8.62e-08	449	62	11	GO:0002449
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IGHV2-70 IGHV2-26 IGHV2-5 CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	1.15e-07	462	62	11	GO:0002460
GeneOntologyBiologicalProcess	intracellular potassium ion homeostasis	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.71e-07	17	62	4	GO:0030007
GeneOntologyBiologicalProcess	response to glycoside	ATP1A1 ATP1A2 ATP1A3	2.58e-07	5	62	3	GO:1903416
GeneOntologyBiologicalProcess	export across plasma membrane	SLC8A1 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.15e-07	91	62	6	GO:0140115
GeneOntologyBiologicalProcess	sodium ion homeostasis	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	4.40e-07	51	62	5	GO:0055078
GeneOntologyBiologicalProcess	leukocyte mediated immunity	IGHV2-70 IGHV2-26 IGHV2-5 CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	1.02e-06	576	62	11	GO:0002443
GeneOntologyBiologicalProcess	cell communication by electrical coupling involved in cardiac conduction	SLC8A1 ATP1A1 ATP1A2 ATP1A3	1.05e-06	26	62	4	GO:0086064
GeneOntologyBiologicalProcess	cell communication by electrical coupling	SLC8A1 ATP1A1 ATP1A2 ATP1A3	3.61e-06	35	62	4	GO:0010644
GeneOntologyBiologicalProcess	potassium ion homeostasis	ATP1A1 ATP1A2 ATP1A3 ATP1A4	4.54e-06	37	62	4	GO:0055075
GeneOntologyBiologicalProcess	potassium ion import across plasma membrane	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.66e-05	51	62	4	GO:1990573
GeneOntologyBiologicalProcess	cell communication involved in cardiac conduction	SLC8A1 ATP1A1 ATP1A2 ATP1A3	2.98e-05	59	62	4	GO:0086065
GeneOntologyBiologicalProcess	relaxation of cardiac muscle	SLC8A1 ATP1A1 ATP1A2	3.31e-05	21	62	3	GO:0055119
GeneOntologyBiologicalProcess	sodium ion transmembrane transport	SLC8A1 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.76e-05	208	62	6	GO:0035725
GeneOntologyBiologicalProcess	immune effector process	IGHV2-70 IGHV2-26 IGHV2-5 CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	4.46e-05	859	62	11	GO:0002252
GeneOntologyBiologicalProcess	inorganic ion import across plasma membrane	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	6.80e-05	142	62	5	GO:0099587
GeneOntologyBiologicalProcess	inorganic cation import across plasma membrane	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	6.80e-05	142	62	5	GO:0098659
GeneOntologyBiologicalProcess	regulation of the force of heart contraction	SLC8A1 ATP1A1 ATP1A2	1.32e-04	33	62	3	GO:0002026
GeneOntologyBiologicalProcess	sodium ion transport	SLC8A1 SLC17A3 ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.75e-04	275	62	6	GO:0006814
GeneOntologyBiologicalProcess	cardiac conduction	SLC8A1 ATP1A1 ATP1A2 ATP1A3	2.34e-04	100	62	4	GO:0061337
GeneOntologyBiologicalProcess	relaxation of muscle	SLC8A1 ATP1A1 ATP1A2	2.73e-04	42	62	3	GO:0090075
GeneOntologyBiologicalProcess	regulation of cardiac muscle cell membrane potential	SLC8A1 ATP1A3	4.80e-04	11	62	2	GO:0086036
GeneOntologyBiologicalProcess	import across plasma membrane	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	6.37e-04	230	62	5	GO:0098739
GeneOntologyBiologicalProcess	potassium ion transmembrane transport	KCNH8 ATP1A1 ATP1A2 ATP1A3 ATP1A4	6.62e-04	232	62	5	GO:0071805
GeneOntologyBiologicalProcess	immunoglobulin production	IGLV9-49 IGLV8-61 IGLV7-46 IGLV7-43 IGLV6-57	7.86e-04	241	62	5	GO:0002377
GeneOntologyBiologicalProcess	brain-derived neurotrophic factor receptor signaling pathway	FSTL4 ATP1A3	7.90e-04	14	62	2	GO:0031547
GeneOntologyBiologicalProcess	L-ascorbic acid metabolic process	ATP1A2 ATP1A3	1.04e-03	16	62	2	GO:0019852
GeneOntologyCellularComponent	immunoglobulin complex	IGHV2-70 IGHV2-26 IGHV2-5 IGLV9-49 IGLV8-61 IGLV7-46 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-4 IGHV2-70D	1.89e-18	166	64	15	GO:0019814
GeneOntologyCellularComponent	sodium:potassium-exchanging ATPase complex	ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.88e-08	12	64	4	GO:0005890
GeneOntologyCellularComponent	cation-transporting ATPase complex	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.53e-05	49	64	4	GO:0090533
GeneOntologyCellularComponent	ATPase dependent transmembrane transport complex	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.42e-05	55	64	4	GO:0098533
GeneOntologyCellularComponent	photoreceptor inner segment membrane	ATP1A1 ATP1A3	5.51e-05	4	64	2	GO:0060342
GeneOntologyCellularComponent	intercalated disc	SLC8A1 ATP1A1 ATP1A2	1.19e-03	68	64	3	GO:0014704
HumanPheno	Episodic quadriplegia	ATP1A2 ATP1A3	6.01e-06	2	13	2	HP:0200072
HumanPheno	Saccadic oscillation	KIF1B ATP1A2 ATP1A3	1.68e-05	21	13	3	HP:0032104
HumanPheno	Episodic hemiplegia	ATP1A2 ATP1A3	3.60e-05	4	13	2	HP:0012194
HumanPheno	Abnormal saccadic eye movements	ATXN7 KIF1B ATP1A2 ATP1A3	6.56e-05	93	13	4	HP:0000570
HumanPheno	Perisylvian polymicrogyria	ATP1A2 ATP1A3 SIX3	8.11e-05	35	13	3	HP:0012650
HumanPheno	Skewfoot	ATP1A2 ATP1A3	8.97e-05	6	13	2	HP:0032649
HumanPheno	Ocular flutter	ATP1A2 ATP1A3	8.97e-05	6	13	2	HP:0031931
HumanPheno	Flushing	KIF1B ATP1A2 ATP1A3	1.97e-04	47	13	3	HP:0031284
HumanPheno	Chorea	ATXN7 NUP62 ATP1A2 ATP1A3 GPR88	2.45e-04	248	13	5	HP:0002072
Domain	P-type_ATPase_IIC	ATP1A1 ATP1A2 ATP1A3 ATP1A4	6.25e-10	6	49	4	IPR005775
Domain	-	ATP1A1 ATP1A2 ATP1A3 ATP1A4	7.43e-08	16	49	4	1.20.1110.10
Domain	ATPase_P-typ_TM_dom	ATP1A1 ATP1A2 ATP1A3 ATP1A4	7.43e-08	16	49	4	IPR023298
Domain	ATPase_P-typ_cation-transptr_C	ATP1A1 ATP1A2 ATP1A3 ATP1A4	9.70e-08	17	49	4	IPR006068
Domain	Cation_ATPase_C	ATP1A1 ATP1A2 ATP1A3 ATP1A4	9.70e-08	17	49	4	PF00689
Domain	Cation_ATPase_N	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.25e-07	18	49	4	PF00690
Domain	Cation_ATPase_N	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.25e-07	18	49	4	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.57e-07	19	49	4	IPR004014
Domain	-	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.42e-06	32	49	4	2.70.150.10
Domain	-	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.42e-06	32	49	4	3.40.1110.10
Domain	ATPase_P-typ_cyto_domN	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.06e-06	35	49	4	IPR023299
Domain	ATPase_P-typ_P_site	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.32e-06	36	49	4	IPR018303
Domain	P_typ_ATPase	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.32e-06	36	49	4	IPR001757
Domain	ATPASE_E1_E2	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.32e-06	36	49	4	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.59e-06	37	49	4	IPR008250
Domain	E1-E2_ATPase	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.59e-06	37	49	4	PF00122
Domain	HAD-like_dom	ATP1A1 ATP1A2 ATP1A3 ATP1A4	5.44e-05	79	49	4	IPR023214
Domain	Kazal_2	SLCO4C1 FSTL4	4.01e-03	36	49	2	PF07648
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	IGHV2-70 IGHV2-5 ATP1A1 ATP1A2 ATP1A3 ATP1A4 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	5.25e-11	154	46	10	M39007
Pathway	REACTOME_SARS_COV_INFECTIONS	IGHV2-70 IGHV2-5 ANO5 NUP62 ATP1A1 ATP1A2 ATP1A3 ATP1A4 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.33e-08	471	46	12	M39009
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	4.18e-08	61	46	6	M27581
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV2-70 IGHV2-5 CD81 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	8.23e-08	115	46	7	M19752
Pathway	REACTOME_FCGR_ACTIVATION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	8.84e-08	69	46	6	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	8.84e-08	69	46	6	M27150
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	8.92e-08	35	46	5	MM17219
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	1.05e-07	71	46	6	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	1.05e-07	71	46	6	M27203
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	1.57e-07	39	46	5	MM17212
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.16e-07	80	46	6	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.50e-07	82	46	6	M27110
Pathway	REACTOME_COMPLEMENT_CASCADE	CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	2.89e-07	84	46	6	MM14653
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	3.28e-07	45	46	5	MM14912
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	3.33e-07	86	46	6	M27206
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	3.33e-07	86	46	6	M601
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	3.57e-07	87	46	6	M27205
Pathway	REACTOME_FCGR_ACTIVATION	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.56e-07	48	46	5	MM17214
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	6.02e-07	95	46	6	M29842
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	7.24e-07	98	46	6	M27152
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	7.55e-07	53	46	5	MM15716
Pathway	REACTOME_ION_HOMEOSTASIS	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	8.30e-07	54	46	5	M27460
Pathway	REACTOME_ION_HOMEOSTASIS	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	8.30e-07	54	46	5	MM15202
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	8.30e-07	54	46	5	MM14655
Pathway	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	ATP1A1 ATP1A2 ATP1A3 ATP1A4	8.40e-07	23	46	4	M4361
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	9.98e-07	56	46	5	MM14815
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	1.19e-06	58	46	5	MM14914
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	1.41e-06	60	46	5	MM14913
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	1.41e-06	60	46	5	MM14872
Pathway	REACTOME_PARASITE_INFECTION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	1.95e-06	116	46	6	M29843
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGHV2-70 IGHV2-5 CD81 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.48e-06	190	46	7	M8240
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGHV2-70 IGHV2-5 CD58 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.85e-06	194	46	7	M16312
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	4.52e-06	134	46	6	M29840
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	CD81 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.72e-06	135	46	6	MM14781
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	4.92e-06	136	46	6	M27207
Pathway	KEGG_CARDIAC_MUSCLE_CONTRACTION	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	5.57e-06	79	46	5	M17673
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	6.58e-06	143	46	6	M27107
Pathway	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.01e-05	42	46	4	M16473
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	1.54e-05	166	46	6	M608
Pathway	REACTOME_VIRAL_INFECTION_PATHWAYS	IGHV2-70 IGHV2-5 ANO5 NUP62 ATP1A1 ATP1A2 ATP1A3 ATP1A4 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	1.92e-05	888	46	12	M48034
Pathway	REACTOME_CARDIAC_CONDUCTION	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.04e-05	103	46	5	MM15196
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.15e-05	176	46	6	MM15718
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	2.45e-05	107	46	5	MM14915
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.68e-05	183	46	6	M997
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.94e-05	186	46	6	M27175
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.00e-05	55	46	4	M971
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	3.33e-05	114	46	5	MM14814
Pathway	REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	ATP1A1 ATP1A2 ATP1A3 ATP1A4	3.45e-05	57	46	4	MM15643
Pathway	REACTOME_CARDIAC_CONDUCTION	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	6.25e-05	130	46	5	M27454
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	6.48e-05	131	46	5	MM15717
Pathway	REACTOME_LEISHMANIA_INFECTION	IGHV2-70 IGHV2-5 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	7.32e-05	219	46	6	M29836
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	1.23e-04	150	46	5	MM14889
Pathway	REACTOME_INFECTIOUS_DISEASE	IGHV2-70 IGHV2-5 ANO5 NUP62 ATP1A1 ATP1A2 ATP1A3 ATP1A4 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	1.31e-04	1081	46	12	M27548
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	1.57e-04	158	46	5	MM14812
Pathway	REACTOME_MUSCLE_CONTRACTION	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.92e-04	165	46	5	MM15026
Pathway	REACTOME_HEMOSTASIS	SLC8A1 IGHV2-70 IGHV2-5 KIF1B CD58 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.93e-04	679	46	9	M8395
Pathway	REACTOME_MUSCLE_CONTRACTION	SLC8A1 ATP1A1 ATP1A2 ATP1A3 ATP1A4	5.00e-04	203	46	5	M5485
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	SLC8A1 SLCO4C1 SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.46e-03	681	46	8	MM14985
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	IGHV2-70 IGHV2-5 KIF1B TBC1D14 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	2.16e-03	725	46	8	M27507
Pathway	REACTOME_HEMOSTASIS	SLC8A1 KIF1B IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	2.34e-03	571	46	7	MM14472
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	SLC8A1 SLCO4C1 SLC17A3 ANO5 ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.38e-03	736	46	8	M27287
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	SLCO4C1 IGHV2-70 IGHV2-5 CD58 CD81 IGLV7-43 MUC3A IGHV4-59 IGLV6-57 IGHV4-39	2.95e-03	1128	46	10	M1036
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	KIF1B TBC1D14 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.59e-03	645	46	7	MM15232
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	IGHV2-70 IGHV2-5 CD81 HECTD1 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	4.88e-03	828	46	8	M1058
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	CD81 HECTD1 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	8.22e-03	719	46	7	MM14540
Pubmed	Structure and function of immunoglobulin genes and precursors.	IGLV8-61 IGLV7-46 IGHV4-61 IGLV7-43 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.86e-21	10	66	8	428562
Pubmed	Cloning, sequencing and expression of the rearranged MOPC 315 VH gene segment.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.41e-13	7	66	5	2497341
Pubmed	The idiotypic network and the internal image: possible regulation of a germ-line network by paucigene encoded Ab2 (anti-idiotypic) antibodies in the GAT system.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.41e-13	7	66	5	3937730
Pubmed	Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.41e-13	7	66	5	268248
Pubmed	The structure of the expressible VH gene from a hybridoma producing monoclonal antibodies against porcine transferrin.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.41e-13	7	66	5	2587273
Pubmed	Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.41e-13	7	66	5	414225
Pubmed	A new germline VH36-60 gene is used in the neonatal primary and adult memory response to (T,G)-A--L.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.41e-13	7	66	5	1683681
Pubmed	Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.41e-13	7	66	5	4524622
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGLV8-61 IGLV7-46 IGHV4-61 IGLV7-43 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	2.06e-12	77	66	8	15608191
Pubmed	Chromosomal organization of the human VH4 gene family. Location of individual gene segments.	IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-2	1.18e-11	4	66	4	8454861
Pubmed	Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia.	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.18e-11	4	66	4	21849490
Pubmed	Multiple genes encode the human Na+,K+-ATPase catalytic subunit.	ATP1A1 ATP1A2 ATP1A3 ATP1A4	5.90e-11	5	66	4	3035563
Pubmed	The family of human Na+,K+-ATPase genes. No less than five genes and/or pseudogenes related to the alpha-subunit.	ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.77e-10	6	66	4	3036582
Pubmed	Physicochemical and functional characterization of the C1r subunit of the first complement component.	IGHV2-70 IGLV8-61 IGLV7-46 IGLV7-43 IGLV6-57 IGHV4-31	3.74e-10	47	66	6	814163
Pubmed	Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse.	ATP1A1 ATP1A2 ATP1A3 ATP1A4	4.12e-10	7	66	4	10837135
Pubmed	Molecular genetics of Na,K-ATPase.	ATP1A1 ATP1A2 ATP1A3 ATP1A4	4.12e-10	7	66	4	2158121
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGHV2-70 IGLV8-61 IGLV7-46 IGLV7-43 IGLV6-57 IGHV4-31	4.26e-10	48	66	6	11955599
Pubmed	The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.	IGHV2-70 IGHV2-26 IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-4	4.56e-10	91	66	7	9841928
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	5.42e-10	22	66	5	2499654
Pubmed	Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit.	SLC8A1 ATP1A1 ATP1A2 ATP1A3	8.23e-10	8	66	4	19683723
Pubmed	The Na(+)-K(+)-ATPase alpha2-subunit isoform modulates contractility in the perinatal mouse diaphragm.	SLC8A1 ATP1A1 ATP1A2 ATP1A3	1.48e-09	9	66	4	15253893
Pubmed	Specificity change of antibody to (4-hydroxy-3-nitrophenyl)acetyl haptens by somatic hypermutation.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	3129412
Pubmed	B cells are programmed to activate kappa and lambda for rearrangement at consecutive developmental stages.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	10427979
Pubmed	Specific V gene usage in anti-phosphorylcholine IgE antibodies.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	8247027
Pubmed	Developmental cell-specific regulation of Na(+)-K(+)-ATPase alpha 1-, alpha 2-, and alpha 3-isoform gene expression.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	8203495
Pubmed	Three differentially expressed Na,K-ATPase alpha subunit isoforms: structural and functional implications.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	2822726
Pubmed	Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	30819023
Pubmed	Amino acid sequences of two mouse immunoglobulin lambda chains.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	5276767
Pubmed	Structural evidence for the functional importance of the heme domain mobility in flavocytochrome b2.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	20546754
Pubmed	Restricted immunoglobulin variable region (Ig V) gene expression accompanies secondary rearrangements of light chain Ig V genes in mouse plasmacytomas.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	10562316
Pubmed	Sequences of mouse immunoglobulin light chain genes before and after somatic changes.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	103630
Pubmed	High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	2117034
Pubmed	Chromosomal location of structural genes encoding murine immunoglobulin lambda light chains. Genetics of murine lambda light chains.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	6265582
Pubmed	Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibody (MabB23) specific for human plasma apolipoprotein B-100.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	8647454
Pubmed	Somatic variants of murine immunoglobulin lambda light chains.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	6283385
Pubmed	Contribution of light chain rearrangement in peripheral B cells to the generation of high-affinity antibodies.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	11920561
Pubmed	A murine antibody to Shigella dysenteriae type 1 employs V-genes that contain a rearranged codon for the lambda light chain.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	7643860
Pubmed	Na,K-ATPase and the role of alpha isoforms in behavior.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	18044013
Pubmed	Amino acid and nucleotide sequences of variable regions of mouse immunoglobulin light chains of the lambda 3-subtype.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	6202790
Pubmed	Genetic polymorphism of lambda 1 and lambda 3 immunoglobulin light chains in the Mus subgenus.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	6189723
Pubmed	Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	14754898
Pubmed	Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	418414
Pubmed	Dual expression of lambda genes in the MOPC-315 plasmacytoma.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	6259534
Pubmed	Natural auto- and polyreactive antibodies differing from antigen-induced antibodies in the H chain CDR3.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	1918968
Pubmed	Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase.	ATP1A1 ATP1A3 ATP1A4	6.53e-09	3	66	3	26373354
Pubmed	Mouse immunoglobulin gene rearrangements. The sequence of a nonexpressed lambda 3-chain gene.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	2987352
Pubmed	Wild mice express an Ig V lambda gene that differs from any V lambda in BALB/c but resembles a human V lambda subgroup.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	1378065
Pubmed	Variable region sequence and characterization of monoclonal antibodies to a N,N',N"-trisubstituted guanidine high potency sweetener.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	8232332
Pubmed	Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	8805642
Pubmed	The alpha 1 isoform of Na,K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart.	SLC8A1 ATP1A1 ATP1A2	6.53e-09	3	66	3	15485817
Pubmed	Amino acid sequence of the NH2-terminal extra piece segments of the precursors of mouse immunoglobulin lambda1-type and kappa-type light chains.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	403522
Pubmed	A linkage map of the mouse immunoglobulin lambda light chain locus.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	2494106
Pubmed	Comparative sequence and immunochemical analyses of murine monoclonal anti-morphine antibodies.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	2555519
Pubmed	Mutational analysis of avidity and fine specificity of anti-levan antibodies.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	10586066
Pubmed	Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	26911348
Pubmed	Nucleotide sequence of a chromosomal rearranged lambda 2 immunoglobulin gene of mouse.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	6287422
Pubmed	Characterization of an inbred mouse exhibiting low responsiveness to phosphorylcholine. Antibodies from low-responder mice suggest gene conversion events within the S107VH gene family.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	2453579
Pubmed	Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	9032408
Pubmed	Differential expression of Na+/K+-ATPase alpha-subunits in mouse hippocampal interneurones and pyramidal cells.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	17947306
Pubmed	Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-315).	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	4760498
Pubmed	Sequences of 12 monoclonal anti-dinitrophenyl spin-label antibodies for NMR studies.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	3375235
Pubmed	Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	2430792
Pubmed	Lambda light chain constant and variable gene complements in wild-derived inbred mouse strains.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	3924628
Pubmed	Preparation of a semisynthetic antibody.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	418802
Pubmed	Functional, molecular and structural characterisation of five anti-Brucella LPS mAb.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	15128040
Pubmed	Physical linkage of the constant region genes for immunoglobulins lambda I and lambda III.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	6267606
Pubmed	Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	25994790
Pubmed	Association between sodium- and potassium-activated adenosine triphosphatase alpha isoforms and bipolar disorders.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	19058785
Pubmed	Mouse lambda-chain sequences.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	4516208
Pubmed	Knockout of sodium pump α3 subunit gene (Atp1a3-/-) results in perinatal seizure and defective respiratory rhythm generation.	ATP1A1 ATP1A2 ATP1A3	6.53e-09	3	66	3	28465228
Pubmed	Organization of immunoglobulin genes.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	98276
Pubmed	Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	8318454
Pubmed	A new V gene expressed in lambda-2 light chains of the mouse.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	3034625
Pubmed	Reactivity and structure of a mouse anti-F(ab')2 IgM. Comparison of its variable region sequences with those of a structurally close polyreactive natural IgM.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	8190131
Pubmed	Molecular and biochemical analyses of combining sites of monoclonal anti-morphine antibodies.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	8417377
Pubmed	Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas.	IGLV8-61 IGLV7-46 IGLV7-43	6.53e-09	3	66	3	3139765
Pubmed	Activation of C1r by proteolytic cleavage.	IGLV8-61 IGLV7-46 IGLV7-43 IGLV6-57 IGHV4-31	1.92e-08	43	66	5	1249422
Pubmed	Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2.	ATP1A1 ATP1A2 ATP1A3	2.61e-08	4	66	3	21731499
Pubmed	The Na,K-ATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice.	ATP1A1 ATP1A2 ATP1A3	2.61e-08	4	66	3	12458206
Pubmed	Somatic point mutations in unrearranged immunoglobulin gene segments encoding the variable region of lambda light chains.	IGLV8-61 IGLV7-46 IGLV7-43	2.61e-08	4	66	3	3109891
Pubmed	Structural repertoire of immunoglobulin λ light chains.	IGLV8-61 IGLV7-46 IGLV7-43	2.61e-08	4	66	3	21365679
Pubmed	B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice.	IGLV8-61 IGLV7-46 IGLV7-43	2.61e-08	4	66	3	7722301
Pubmed	Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.	ATP1A1 ATP1A2 ATP1A3	2.61e-08	4	66	3	19751721
Pubmed	Linkage of the Igl-1 structural and regulatory genes to Akv-2 on chromosome 16.	IGLV8-61 IGLV7-46 IGLV7-43	2.61e-08	4	66	3	6429038
Pubmed	Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction.	ATP1A1 ATP1A2 ATP1A3	2.61e-08	4	66	3	19376779
Pubmed	Coordinated regulation of cardiac Na(+)/Ca (2+) exchanger and Na (+)-K (+)-ATPase by phospholemman (FXYD1).	SLC8A1 ATP1A1 ATP1A2	2.61e-08	4	66	3	23224879
Pubmed	Muscle Na+-K+-ATPase activity and isoform adaptations to intense interval exercise and training in well-trained athletes.	ATP1A1 ATP1A2 ATP1A3	2.61e-08	4	66	3	17446412
Pubmed	Deficiency in Na,K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice.	ATP1A1 ATP1A2 ATP1A3	2.61e-08	4	66	3	17234593
Pubmed	Family of Na+,K+-ATPase genes. Intra-individual tissue-specific restriction fragment length polymorphism.	ATP1A1 ATP1A3 ATP1A4	2.61e-08	4	66	3	2887455
Pubmed	The anti-DNA-associated idiotype 8.12 is encoded by the V lambda II gene family and maps to the vicinity of L chain CDR1.	IGLV8-61 IGLV7-46 IGLV7-43	2.61e-08	4	66	3	1431128
Pubmed	Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice.	IGLV8-61 IGLV7-46 IGLV7-43	6.51e-08	5	66	3	1512540
Pubmed	Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain.	SLC8A1 ATP1A1 ATP1A2	6.51e-08	5	66	3	16292983
Pubmed	Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus.	IGLV8-61 IGLV7-46 IGLV7-43	6.51e-08	5	66	3	7532679
Pubmed	Transport and pharmacological properties of nine different human Na, K-ATPase isozymes.	ATP1A1 ATP1A2 ATP1A3	1.30e-07	6	66	3	10636900
Pubmed	Expression and distribution of Na, K-ATPase isoforms in the human uterus.	ATP1A1 ATP1A2 ATP1A3	2.27e-07	7	66	3	20065300
Pubmed	Biology, structure and mechanism of P-type ATPases.	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.71e-07	29	66	4	15071553
Pubmed	Genes encoding alpha and beta subunits of Na,K-ATPase are located on three different chromosomes in the mouse.	ATP1A1 ATP1A2 ATP1A3	3.63e-07	8	66	3	2885848
Pubmed	Enhanced inhibitory neurotransmission in the cerebellar cortex of Atp1a3-deficient heterozygous mice.	ATP1A1 ATP1A2 ATP1A3	3.63e-07	8	66	3	23652595
Pubmed	Cloning and complete nucleotide sequence of mouse immunoglobulin gamma 1 chain gene.	IGLV8-61 IGLV7-46 IGLV7-43	5.44e-07	9	66	3	115593
Pubmed	Characterization of the opposite-strand genes from the mouse bidirectionally transcribed HTF9 locus.	IGLV8-61 IGLV7-46 IGLV7-43	5.44e-07	9	66	3	1889746
Cytoband	14q32.33	IGHV2-70 IGHV2-26 IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-30-2 IGHV4-4	1.24e-12	228	66	10	14q32.33
Cytoband	Ensembl 112 genes in cytogenetic band chr14q32	IGHV2-70 IGHV2-26 IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4 IGHV2-70D	1.22e-07	566	66	9	chr14q32
Cytoband	22q11.2	IGLV9-49 IGLV8-61 IGLV7-46 IGLV7-43 IGLV6-57	8.83e-07	120	66	5	22q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr22q11	IGLV9-49 IGLV8-61 IGLV7-46 IGLV7-43 IGLV6-57	3.50e-04	419	66	5	chr22q11
Cytoband	1q23.2	ATP1A2 ATP1A4	1.17e-03	35	66	2	1q23.2
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV2-70 IGHV2-26 IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-30-4 IGHV4-30-2 IGHV4-4 IGHV2-70D	1.07e-11	187	56	11	349
GeneFamily	ATPase Na+/K+ transporting subunits	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.87e-09	7	56	4	1208
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV9-49 IGLV8-61 IGLV7-46 IGLV7-43 IGLV6-57	8.09e-06	89	56	5	353
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFHX4 ZHX2	9.64e-04	15	56	2	529
GeneFamily	CD molecules\|Mucins	MUC2 MUC3A	1.91e-03	21	56	2	648
GeneFamily	Solute carriers	SLC25A41 SLC8A1 SLC25A35 SLCO4C1 SLC17A3	7.44e-03	395	56	5	752
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	IGHV2-5 IGLV7-46 MUC2 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4 GFRA2	3.01e-08	183	57	8	Arv_SC-HD_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	IGHV2-5 IGLV7-46 MUC2 IGHV4-59 IGHV4-39 IGHV4-31	9.51e-06	183	57	6	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	IGLV7-46 MUC2 IGHV4-59 IGHV4-39 IGHV4-4	2.22e-05	126	57	5	Arv_SC-HD_500_K2
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3	IGLV7-46 MUC2 IGHV4-59 IGHV4-39 IGHV4-4	3.56e-05	139	57	5	Arv_SC_fibroblast_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4	IGHV2-5 IGLV7-46 MUC2 IGHV4-61 IGHV4-59 IGHV4-39	4.81e-05	244	57	6	Arv_SC-H9hpx_1000_K4
CoexpressionAtlas	ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3	ZFHX4 IGHV2-5 SIX3 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 CDH8 IGHV4-4	7.69e-05	848	57	10	ratio_ECTO_vs_SC_2500_K3
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2	IGHV2-5 IGLV7-46 MUC2 IGHV4-61 IGHV4-59 IGHV4-39	7.76e-05	266	57	6	Arv_SC-hpx_blastocyst_1000_K2
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_2500_k-means-cluster#4	IGHV2-5 ATP1A2 IGLV7-46 IGHV4-61 IGHV4-4 GFRA2	1.95e-04	315	57	6	Arv_SC-HD_2500_K4
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000	SALL2 IGHV2-5 IGLV7-46 MUC2 MUC3A IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4 GFRA2	2.63e-04	986	57	10	Arv_SC-HD_1000
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000	SALL2 IGHV2-5 IGLV7-46 MUC2 MUC3A IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4 GFRA2	2.63e-04	986	57	10	Arv_SC_fibroblast_1000
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#5	IGHV2-5 ATP1A2 IGLV7-46 IGHV4-61 IGHV4-4 GFRA2	2.99e-04	341	57	6	Arv_SC_fibroblast_2500_K5
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGHV2-26 IGLV9-49 IGLV8-61 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4 STARD5	1.78e-15	176	65	11	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGHV2-5 IGLV9-49 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 STARD5	3.38e-12	170	65	9	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-26 IGHV2-5 IGLV9-49 IGLV8-61 IGLV7-46 IGHV4-59 IGLV6-57 IGHV4-39 IGHV2-70D	3.96e-12	173	65	9	0ca2169a275404118038c0489a48062879488765
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV2-5 IGLV9-49 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	1.16e-11	195	65	9	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV2-70 IGLV8-61 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	1.22e-11	196	65	9	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGLV9-49 IGLV8-61 IGLV7-46 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	3.50e-11	142	65	8	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	tumor_Lung-B_lymphocytes-Plasma_cells\|tumor_Lung / Location, Cell class and cell subclass	IGHV2-70 IGHV2-5 IGLV9-49 IGLV8-61 IGLV7-43 IGLV6-57 IGHV4-39 IGHV4-31	1.41e-10	169	65	8	b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-70 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2 IGHV2-70D	1.70e-10	173	65	8	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGLV9-49 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	2.66e-10	183	65	8	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-70 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2 IGHV2-70D	2.90e-10	185	65	8	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-70 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2 IGHV2-70D	2.90e-10	185	65	8	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-70 IGHV2-5 IGLV9-49 IGLV7-46 IGHV4-59 IGLV6-57 IGHV4-39 IGHV2-70D	3.30e-10	188	65	8	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV2-70 IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	4.23e-10	194	65	8	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGHV2-70 IGLV9-49 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	4.40e-10	195	65	8	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGHV2-5 IGLV9-49 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	4.59e-10	196	65	8	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGLV7-46 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	4.78e-10	197	65	8	fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH8 IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	4.78e-10	197	65	8	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH8 IGHV2-26 IGHV2-5 IGLV9-49 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	5.17e-10	199	65	8	8e02d3a066e79e0f2024a10738e0ea070513ef19
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	5.40e-09	169	65	7	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGHV2-70 IGHV2-26 IGLV7-46 IGHV4-59 IGHV4-39 IGHV4-31 IGHV2-70D	7.15e-09	176	65	7	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGLV9-49 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	7.44e-09	177	65	7	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV2-70 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV2-70D	7.73e-09	178	65	7	2e51c1596022b7047994ee13c18375bad19a54a5
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-31 IGHV4-4 IGHV2-70D	8.35e-09	180	65	7	6a777a308fa3160d31eda468db930e71862020b2
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV2-70 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV2-70D	8.68e-09	181	65	7	e7d9910f6143055645b6f03b1018282e6c215f10
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2 IGHV2-70D	8.68e-09	181	65	7	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	8.68e-09	181	65	7	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	IGLV9-49 IGLV8-61 IGLV7-46 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	9.02e-09	182	65	7	27d1688fdfc570cedd233aa7030bce7d9b604d42
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	9.36e-09	183	65	7	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	9.36e-09	183	65	7	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	9.72e-09	184	65	7	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	9.72e-09	184	65	7	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-26 IGHV2-5 IGLV9-49 IGLV7-46 IGHV4-59 IGLV6-57 IGHV4-39	9.72e-09	184	65	7	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-26 IGHV2-5 IGLV9-49 IGLV7-46 IGHV4-59 IGLV6-57 IGHV4-39	9.72e-09	184	65	7	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	1.01e-08	185	65	7	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV2-5 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	1.21e-08	190	65	7	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV2-5 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	1.21e-08	190	65	7	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV2-5 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	1.26e-08	191	65	7	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV2-70 IGHV2-5 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	1.35e-08	193	65	7	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGLV8-61 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-31 IGHV4-4	1.35e-08	193	65	7	7b4b0271e4fbece703876acb053ae236afb7cdba
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV8-61 IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	1.35e-08	193	65	7	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV2-70 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	1.50e-08	196	65	7	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV2-70 IGHV2-26 IGHV2-5 IGLV8-61 IGHV4-59 IGLV6-57 IGHV4-4	1.50e-08	196	65	7	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH8 IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	1.56e-08	197	65	7	88b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCell	Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV2-26 IGHV2-5 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4 STARD5	1.56e-08	197	65	7	365654a344bfdd2533cfcbed05063427b40f47b9
ToppCell	Parenchyma_COVID-19-Immune-TX-Plasma_cells\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	IGHV2-26 IGHV2-5 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4 STARD5	1.56e-08	197	65	7	3259d7ce3e6dde1beda8b534bdf7ff5c7fc1a46c
ToppCell	Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV2-26 IGHV2-5 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4 STARD5	1.56e-08	197	65	7	9936dc179aa0cf8aadf77946b26c09ad33848dc2
ToppCell	Lung_Parenchyma-Severe-Lymphocyte-B-Plasmablast-Plasmablast-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV2-26 IGHV2-5 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4 STARD5	1.56e-08	197	65	7	5474774c2ff7a13ec1a020e2fef4efa72e34727b
ToppCell	Lung_Parenchyma-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV2-26 IGHV2-5 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4 STARD5	1.56e-08	197	65	7	9e0850b6bb952757c74ba816e30006199e562bfa
ToppCell	343B-Lymphocytic-Plasma_cell-\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGHV2-5 IGLV8-61 IGLV6-57 IGHV4-31 IGHV4-4 STARD5	1.14e-07	157	65	6	554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8
ToppCell	343B-Lymphocytic-Plasma_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGHV2-5 IGLV8-61 IGLV6-57 IGHV4-31 IGHV4-4 STARD5	1.14e-07	157	65	6	2cb3deb5313ce734710c601935ca318e4179077e
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGHV2-70 IGHV2-5 IGLV8-61 IGHV4-59 IGLV6-57 IGHV4-39	1.23e-07	159	65	6	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	1.38e-07	162	65	6	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	1.38e-07	162	65	6	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	10x5'-GI_large-bowel\|World / Manually curated celltypes from each tissue	MUC2 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	1.71e-07	168	65	6	1290c909655bc37f6b8bf216d18127a21b99e9c0
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31	1.83e-07	170	65	6	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31	1.83e-07	170	65	6	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH8 IGLV8-61 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31	1.83e-07	170	65	6	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	10x5'-Lung-Lymphocytic_B-Memory_B_cells\|Lung / Manually curated celltypes from each tissue	KCNH8 IGHV2-5 IGLV9-49 IGLV8-61 MUC2 IGHV4-59	1.96e-07	172	65	6	2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	IGHV2-70 CD58 IGLV9-49 IGHV4-61 IGLV7-43 IGHV4-59	2.17e-07	175	65	6	fa53ea81ad943a2cd266114829135cbcbcf2f634
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	2.24e-07	176	65	6	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	2.24e-07	176	65	6	4b4416f342b732d2cc60133838728880326257d8
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGLV8-61 IGHV4-59 IGLV6-57 IGHV4-39 STARD5 IGHV2-70D	2.32e-07	177	65	6	c2b0fb5921eea24d248d6e6ccb57c29b0832602c
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4	2.32e-07	177	65	6	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4	2.32e-07	177	65	6	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGLV8-61 IGHV4-59 IGLV6-57 IGHV4-39 STARD5 IGHV2-70D	2.32e-07	177	65	6	111fb0707ff37ca631d85bb5a09e067ffe568eb8
ToppCell	Healthy-Plasmablast\|Healthy / disease group, cell group and cell class	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	2.32e-07	177	65	6	4ff75c609ac9edf7a94bda42eb7124c559e8b6aa
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4	2.32e-07	177	65	6	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNH8 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	2.40e-07	178	65	6	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4	2.48e-07	179	65	6	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4	2.48e-07	179	65	6	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4	2.48e-07	179	65	6	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-5 IGLV9-49 IGLV7-46 IGLV7-43 IGLV6-57 IGHV4-39	2.56e-07	180	65	6	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-26 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	2.56e-07	180	65	6	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	2.82e-07	183	65	6	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	2.82e-07	183	65	6	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV2-5 IGLV9-49 IGLV8-61 IGLV7-43 IGHV4-39 IGHV4-30-2	3.01e-07	185	65	6	0fa7970709dc957dea95fabbd83263a0335babd5
ToppCell	metastatic_Brain-B_lymphocytes\|metastatic_Brain / Location, Cell class and cell subclass	IGLV9-49 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-31 STARD5	3.01e-07	185	65	6	153b82dc5ace03f84dc82d724d56bdc93aa020df
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV2-5 IGLV9-49 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39	3.01e-07	185	65	6	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV2-5 IGLV9-49 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39	3.01e-07	185	65	6	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	10x5'-Liver-Lymphocytic_B_plasma\|Liver / Manually curated celltypes from each tissue	IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-30-2	3.11e-07	186	65	6	a2c7430781f432c9c90ac4d620f4518ff767a223
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	3.11e-07	186	65	6	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	3.11e-07	186	65	6	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	3.21e-07	187	65	6	c80e03d5aa498b4eecbc46565fabf9b5be10c71c
ToppCell	cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGLV9-49 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 STARD5	3.31e-07	188	65	6	33360f1c30315d9772731c9067834dc059172b79
ToppCell	COVID-19-lung-Plasmablasts\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NACA IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39	3.41e-07	189	65	6	fdf6c945b352614885e646a5ef4bc576dee73895
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	SLC8A1 ZFHX4 ATP1A1 ATP1A3 GPR88 SIX3	3.52e-07	190	65	6	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	3.98e-07	194	65	6	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV8-61 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-31 IGHV4-4	4.10e-07	195	65	6	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGHV2-5 IGHV4-61 IGLV7-43 IGHV4-59 IGLV6-57 IGHV4-39	4.22e-07	196	65	6	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGLV7-46 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31	4.35e-07	197	65	6	2662138671262b30508c5759038bcdcfe6551696
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH8 IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31	4.35e-07	197	65	6	76465bb2408c7c75f694e8f7cf1a606b796afc3a
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-31 IGHV4-4	4.35e-07	197	65	6	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KCNH8 IGHV2-5 IGHV4-61 IGLV7-43 IGHV4-59 IGHV4-39	4.48e-07	198	65	6	d51ee880acc5804cd918105fac846a1528333d6c
ToppCell	Control-Control-Lymphocyte-B-Plasmablast\|Control / Disease, condition lineage and cell class	IGHV2-5 IGHV4-61 IGHV4-59 IGHV4-39 IGHV4-31 IGHV4-4	4.62e-07	199	65	6	c11aa8bca3723a886e7082ae48bb922dd8396be4
ToppCell	343B-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGHV2-5 IGLV8-61 IGLV6-57 IGHV4-31 IGHV4-4	4.19e-06	164	65	5	cf62d34ce9dd220fe61748466c84fd70d9ba697c
ToppCell	343B-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGHV2-5 IGLV8-61 IGLV6-57 IGHV4-31 IGHV4-4	4.19e-06	164	65	5	e00549bc8b3a5566f39031f39d7e698b0b107a7f
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-39 IGHV4-4	4.45e-06	166	65	5	2b7b580bec8d9467b0deaf97098065f72dbf2a4f
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-30-2	5.29e-06	172	65	5	172e3c78f8e97988a4fd8624514e731282ddc16d
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-30-2	5.29e-06	172	65	5	5fb0ea6145892a258696197b3feed9760187e712
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV2-5 IGHV4-61 IGHV4-59 IGLV6-57 IGHV4-30-2	5.29e-06	172	65	5	2214cc37d7c21b868768d3f74ca4631d339d37b3
Drug	thevetin A	ATP1A1 ATP1A2 ATP1A3	1.12e-07	5	52	3	CID000441873
Drug	22,23-dihydrobufalin	ATP1A1 ATP1A2 ATP1A3	1.12e-07	5	52	3	CID000195392
Drug	3-acetylstrophanthin	ATP1A1 ATP1A2 ATP1A3	1.12e-07	5	52	3	CID003082282
Drug	ETH157	ATP1A1 ATP1A2 ATP1A3	2.24e-07	6	52	3	CID000563154
Drug	dihydrodigitoxigenin	ATP1A1 ATP1A2 ATP1A3	3.91e-07	7	52	3	CID000107549
Drug	ouabagenin	ATP1A1 ATP1A2 ATP1A3	1.83e-06	11	52	3	CID000010497
Drug	A-32686	ATP1A1 ATP1A2 ATP1A3	3.16e-06	13	52	3	CID000004951
Drug	HDMA	ATP1A1 ATP1A2 ATP1A3	7.47e-06	17	52	3	CID000131092
Drug	AC1L1F3Q	ATP1A1 ATP1A2 ATP1A3	8.95e-06	18	52	3	CID000003068
Drug	NSC 234205	ATP1A1 ATP1A2 ATP1A3	8.95e-06	18	52	3	CID000010104
Drug	acetylstrophanthidin	ATP1A1 ATP1A2 ATP1A3	8.95e-06	18	52	3	CID000006062
Drug	Cymarigenen	ATP1A1 ATP1A2 ATP1A3	1.25e-05	20	52	3	CID000005303
Drug	AC1NST54	ATP1A1 ATP1A2 ATP1A3	1.45e-05	21	52	3	CID005315525
Drug	cardenolide	ATP1A1 ATP1A2 ATP1A3	1.93e-05	23	52	3	CID000016142
Drug	Digocin	SLCO4C1 ATP1A1 ATP1A2 ATP1A3	1.98e-05	70	52	4	CID000003062
Drug	NSC294864	ATP1A1 ATP1A2 ATP1A3 CLDN2	2.61e-05	75	52	4	CID000325714
Drug	AS701	ATP1A2 ATP1A3	3.06e-05	4	52	2	CID000133528
Drug	dihydropyrone	ATP1A2 ATP1A3	1.07e-04	7	52	2	CID000010760
Drug	N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine	ATP1A2 ATP1A3	1.07e-04	7	52	2	ctd:C481648
Drug	CID6432277	ATP1A1 ATP1A2 ATP1A3	1.13e-04	41	52	3	CID006432277
Drug	glutaconyl-CoA	ATP1A2 ATP1A3	1.42e-04	8	52	2	CID009543049
Drug	alpha-methyl-D-mannoside	NACA ATP1A1 ATP1A2 ATP1A3	1.43e-04	116	52	4	CID000002108
Drug	Ouabain	SLC8A1 ATP1A1 ATP1A2 ATP1A3	1.58e-04	119	52	4	ctd:D010042
Drug	Digoxin	ATP1A1 ATP1A2 ATP1A3	1.59e-04	46	52	3	ctd:D004077
Drug	AC1MBZB6	ATP1A1 ATP1A3	1.82e-04	9	52	2	CID002733620
Drug	amyl nitrite	ATP1A1 ATP1A2 ATP1A3	2.43e-04	53	52	3	CID000008053
Disease	nervous system disease (implicated_via_orthology)	KIF1B ATP1A1 ATP1A2 ATP1A3 ATP1A4	1.61e-11	12	56	5	DOID:863 (implicated_via_orthology)
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A1 ATP1A2 ATP1A3 ATP1A4	4.05e-10	7	56	4	DOID:0060178 (implicated_via_orthology)
Disease	alternating hemiplegia of childhood (is_implicated_in)	ATP1A2 ATP1A3	3.54e-06	2	56	2	DOID:0050635 (is_implicated_in)
Disease	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	ATP1A2 ATP1A3	3.54e-06	2	56	2	C3549447
Disease	Alternating hemiplegia of childhood	ATP1A2 ATP1A3	2.12e-05	4	56	2	C0338488
Disease	cups of coffee per day measurement	ATP1A1 ATP1A3 ATP1A4	6.09e-05	40	56	3	EFO_0006782
Disease	abdominal adipose tissue measurement	ATP1A1 ATP1A3 ATP1A4	1.42e-04	53	56	3	EFO_0803316
Disease	hyperhomocysteinemia (biomarker_via_orthology)	ATP1A1 ATP1A2	2.31e-04	12	56	2	DOID:9279 (biomarker_via_orthology)
Disease	epilepsy (implicated_via_orthology)	ATP1A1 ATP1A2 ATP1A3 ATP1A4	2.64e-04	163	56	4	DOID:1826 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	ATP1A1 ATP1A2 ATP1A3 ATP1A4	5.19e-04	195	56	4	DOID:1574 (implicated_via_orthology)
Disease	cholesteryl ester 18:2 measurement	FSTL4 GFRA2	1.80e-03	33	56	2	EFO_0010345

Protein segments in the cluster

Peptide	Gene	Start	Entry
TTTSLCELGFSILTQ	FAM200B	606	P0CF97
SFLTPQITTSLTGSC	ANO5	506	Q75V66
LLGSVSSCSSTSSLE	CLIP4	421	Q8N3C7
CCGSSTLTALTTSVL	CD81	156	P60033
ATSLISCATGSTTEI	RBM41	396	Q96IZ5
FLECSGVSTITATSL	RAD17	26	O75943
ITATALLTLSCGLST	SLC17A3	316	O00476
STSTSSTTGGSLLLL	GPR88	6	Q9GZN0
TTSSIILTTCIPSSG	CD58	196	P19256
QSPVSICSSSTSLSL	MAGEC1	741	O60732
TLSLTCTVSGGSISS	IGHV4-31	36	P0DP07
TLSLTCAVSGGSISS	IGHV4-4	36	A0A075B6R2
TLTLTCTFSGFSLST	IGHV2-70D	36	A0A0C4DH43
CSLSSQVGLTSVTSI	KIF1B	446	O60333
TLGSTSTICSDKTGT	ATP1A1	366	P05023
TLSLTCAVSGGSISS	IGHV4-30-2	36	A0A087WSY4
ICSSTLLPSTTSSSV	KIAA2026	1401	Q5HYC2
ASVCSTRLGSTKSLT	KIAA1109	1311	Q2LD37
LTIESTLITACSSES	KIAA1109	3366	Q2LD37
TLTLTCTVSGFSLSN	IGHV2-26	36	A0A0B4J1V2
TLSLTCTVSGGSISS	IGHV4-30-4	36	P0DP06
TLSLTCTVSGGSVSS	IGHV4-61	36	A0A0C4DH41
TVTISCTGSSGSIAS	IGLV6-57	36	P01721
ASLGASVTLTCTLSS	IGLV9-49	31	A0A0B4J1Y8
SATDLSLSLCTLSTT	OR51F2	81	Q8NH61
CSITTRPSTLTTFTT	MUC2	1256	Q02817
ITSTDSTLTSSLLTT	MUC3A	1266	Q02505
SETLSLTCTVSGGSI	IGHV4-39	41	P01824
CVTSLDSAILTSSSI	AP5M1	271	Q9H0R1
TLTLTCTFSGFSLST	IGHV2-70	36	P01814
SSATTGLSLCTPVTT	NUP62	231	P37198
TLSLTCTVSGGSISS	IGHV4-59	36	P01825
AATVSTSPVLLSSTC	ATXN7	596	O15265
TLTLTCTFSGFSLST	IGHV2-5	36	P01817
TVTLTCASSTGAVTS	IGLV7-43	36	P04211
TVTLTCGLSSGSVST	IGLV8-61	41	A0A075B6I0
GSTSTICSDKTGTLT	ATP1A2	366	P50993
VSTIVSLLSTLCRGS	HECTD1	276	Q9ULT8
STSLGTSVITTCTSV	GFRA2	391	O00451
SVTTVTVGLSTVLTC	FSTL4	256	Q6MZW2
TIRSLTIGCSSCSSL	HAUS7	136	Q99871
ATITSRGSSLSGSLC	LURAP1L	136	Q8IV03
SGSLCSLLESQSTSL	LURAP1L	146	Q8IV03
TLGSTSTICSDKTGT	ATP1A3	356	P13637
TSSAISSLACIISVV	CLDN2	86	P57739
SLETSCTPSTTSAIL	EMILIN3	516	Q9NT22
LSSTSTLTIRVCGCS	CDH8	586	P55286
SSASITTGITLTTDC	CGRRF1	76	Q99675
VIVGSSTQLCTFSST	SLC25A35	176	Q3KQZ1
TTALSATESLTLLST	SALL2	481	Q9Y467
TVTLTCGSSTGAVTS	IGLV7-46	36	A0A075B6I9
SLTLLSLSSISECNS	MAP3K9	831	P80192
TGTSILSVTSSDSEC	SIX3	316	O95343
SGLVSLSSVTLSTTC	SLC25A41	281	Q8N5S1
GSCRDLLNSSITSTT	SECISBP2L	966	Q93073
ESGCHTTTTSSLVSL	NINL	291	Q9Y2I6
TTTTSSLVSLCSSLR	NINL	296	Q9Y2I6
ISSVTSTCSSLPSVS	ANKHD1	1976	Q8IWZ3
GSTSTICSDKTGTLT	ATP1A4	376	Q13733
ETLCSELTRVLSSSS	ATG4D	406	Q86TL0
VCSVSSLGTELSTTL	TBC1D14	156	Q9P2M4
TTSVITSCSLTSSSL	UBAP2	591	Q5T6F2
LPSTVTSSLCSTSGV	ZFHX4	3501	Q86UP3
TSSLCSTSGVQTSLP	ZFHX4	3506	Q86UP3
CLVLSTSSEALITTG	SLCO4C1	386	Q6ZQN7
SITDTLCVSRTSTPS	STARD5	91	Q9NSY2
TLSITSSGSAVSCST	RIOK2	481	Q9BVS4
SSLLSATCNTFITTL	PLEKHA3	156	Q9HB20
LVLTQVTSGSTTVSC	ZHX2	376	Q9Y6X8
VTSGSTTVSCSPITL	ZHX2	381	Q9Y6X8
TPLQSISATLSSSVC	KCNH8	1021	Q96L42
STLACLGSPSTATVT	SLC8A1	516	P32418
STISSITCSPSGSLN	NACA	386	E9PAV3